News
SURNF
0.218
NaN%
--
SureNano grants 1,500,000 stock options at exercise price CAD $0.30
PUBT · 5d ago
SureNano Science Initiates FDA Stage GLP Toxicology and Pharmacology Studies for GLP GEP-44 and Enters Discussions to Acquire Ibogaine Formulation IP Portfolio
Newsfile · 5d ago
SureNano Science Completes GlucaPharm Acquisition
Reuters · 02/23 14:02
SureNano Science Ltd. Acquires GlucaPharm Inc., Advancing Second-Generation FDA Pathway GLP-1 Drug Development
Newsfile · 02/23 14:00
SureNano Science Grants 1.5 Million Stock Options to Directors, Officers, and Consultants
Reuters · 12/12/2025 14:18
SureNano Announces Stock Option Grant
Newsfile · 12/12/2025 14:18
SureNano Science Raises $1.25 Million in Private Placement
Reuters · 12/10/2025 14:02
SureNano Announces Closing of $1,250,000 Private Placement
Newsfile · 12/10/2025 14:00
SureNano Science Enters LOI to Acquire GlucaPharm for GLP-1 Drug Development
Reuters · 11/19/2025 21:31
SureNano Announces Non-Binding Letter of Intent to Negotiate Proposed Transaction of GlucaPharm Inc. for GLP-1 Drug Development
Newsfile · 11/19/2025 21:30
SureNano Science to raise $1.25M via private placement
Seeking Alpha · 11/06/2025 10:20
SureNano Science Launches $1.25 Million Private Placement
Reuters · 11/05/2025 23:37
SureNano Announces Private Placement
Newsfile · 11/05/2025 23:36
SureNano Closes Financing
Newsfile · 09/19/2025 20:30
SureNano Science Ltd. Held Annual General and Special Meeting
Reuters · 08/22/2025 13:01
SureNano Announces Funding, Debt Settlement and AGSM Results
Newsfile · 08/22/2025 13:00
More
Webull provides a variety of real-time SURNF stock news. You can receive the latest news about SureNano Science through multiple platforms. This information may help you make smarter investment decisions.
About SURNF
SureNano Science Ltd. is a Canada-based company. The principal business of the Company is the sale and distribution of the SureNano surfactant, which is a ready-to-mix food grade compound that provides the base for high performance nano-emulsions to create incredibly homogeneous and stable products while maximizing bioavailability, clarity and taste. The Company has licenses to distribute the SureNano surfactant within Canada, the State of Oklahoma, the United States, and the State of Colorado, United States. SureNano includes Free Flavor technology designed specifically to reduce the naturally bitter notes of many cannabinoids included Cannabidiol (CBD) and tetrahydrocannabinol (THC). It is also developing GEP44, a patented peptide targeting obesity and metabolic disorders with improved tolerability and potential non-injectable delivery.